Phase i dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma

Farrukh T. Awan, Joseph M. Flynn, Jeffrey A. Jones, Leslie A. Andritsos, Kami J. Maddocks, Ellen J. Sass, Margaret S. Lucas, Weihong Chase, Sharon Waymer, Yonghua Ling, Yao Jiang, Mitch A. Phelps, John C. Byrd, David M. Lucas, Jennifer A. Woyach

Research output: Contribution to journal › Article › peer-review